Medit Announces "Glow Together" International Women's Day Campaign

by | PRNewswire Asia

SEOUL, South Korea, Feb. 27, 2026 /PRNewswire/ — Medit, a global provider of digital dentistry solutions, today announced that the "Glow Together" campaign will begin this March. The ‘Glow Together’ initiative began with small steps taken...

ASEAN Foundation introduced CALM MRI: Children and the No Longer Scary Machine

by | PRNewswire Asia

SINGAPORE, Feb. 27, 2026 /PRNewswire/ — The ASEAN Foundation organized the regional programme "CALM MRI – Fear to Confidence: Learning through Play with LEGO MRI Kits Programme", implemented across Indonesia and Singapore. The initiative serves as...

RIMAN Honored with iF DESIGN AWARD 2026, Strengthening Its Global Brand Leadership

by | PRNewswire Asia

SEOUL, South Korea, Feb. 27, 2026 /PRNewswire/ — RIMAN, a premium Korean skincare and wellness brand, announced its ICD Dermatology Line, featuring boosters, serums, and creams, has received the iF DESIGN AWARD 2026 in the Packaging Design category. The...

Powered by Physical AI: Envision Sets Sail with World's First Commercial Green Ammonia Cargo to South Korea

by | PRNewswire Asia

CHIFENG, China, Feb. 27, 2026 /PRNewswire/ — Envision, a world-leading green technology company launched the first global shipment of green ammonia from Chifeng, Inner Mongolia to LOTTE Fine Chemical, a premier chemical company in South Korea. This...

Cynosure Lutronic bolsters its strength in APAC — The world's fastest-growing medical aesthetics device region, with dual regulatory approvals for the Clarity II™ in China and Japan, February 2026

by | PRNewswire Asia

SINGAPORE, Feb. 27, 2026 /PRNewswire/ — Cynosure Lutronic, a global leader in energy-based medical aesthetic devices, announced today that Clarity II, its dual-wavelength long-pulse laser platform, has received regulatory approval in...

SK bioscience, IDT Biologika and Vaxxas Selected for Next-Generation Influenza Vaccine development Financed by the European Union

by | PRNewswire Asia

SK–IDT–Vaxxas consortium establishes strategic entry point for high-density microarray patch (HD-MAP) vaccines in Europe to improve vaccine performance and access. Parallel development of high-immunogenicity HD-MAP vaccines for seasonal and pandemic influenza threats....